Campbell Drug: Claims for Undispensed Drugs and the Default Judgment

The Campbell Drug judgment totaled $3,423,390 for alleged pharmacy billing fraud involving drugs without valid prescriptions, drugs never dispensed and brand-name claims for generics. The federal court in Nebraska entered the default judgment against the pharmacy and its owner on May 29, 2026. The alleged billing put taxpayers on the hook for medicine patients never received and brand-name drugs the pharmacy never supplied.

Campbell Drug was a pharmacy in Oshkosh, Nebraska, billing Medicare and Medicaid. The Justice Department’s announcement described allegations that its owner knew the billing methods were improper and continued using them for monetary benefit. Neither the pharmacy nor its owner defended against the government’s allegations.

The case puts a concrete pharmacy transaction at the center of pharmaceutical fraud cases. Did a valid prescription exist? Was the drug dispensed? Did the claim identify the drug actually supplied?

What Campbell Drug Allegedly Billed Medicare and Medicaid For

The government alleged that Campbell Drug billed Medicaid for drugs without valid prescriptions and for drugs never dispensed. It also alleged that both Medicare and Medicaid received claims for brand-name medications when the pharmacy supplied generics.

Prescription Drugs Without Valid Prescriptions

According to the complaint as described by the Justice Department, the owner sought Medicaid reimbursement for prescription drugs for which valid prescriptions had never been issued.

A 2020 University of Portsmouth doctoral study, Exploring U.S. Pharmacists’ Willingness to Fill Prescriptions Illegally, presented working pharmacists with hypothetical dispensing decisions. In one, a patient pressed for a refill after authorized refills had run out. In the study’s table for that scenario, 50.6% said they would dispense it. The study identified patient health and professional judgment as reasons respondents gave for that choice.

A pharmacist’s reason for supplying a drug and the prescriber’s authorization are separate pieces of the story. In a case involving claims without valid prescriptions, we want to understand both.

Drugs Billed but Never Dispensed

The government separately alleged that Campbell Drug billed Medicaid for prescription drugs that were never dispensed.

A pharmacy employee may know the handover never occurred while someone working on claims sees the bill proceeding through the payment system. Bringing those views together is the practical value of an insider’s account: the billing record can describe a transaction that the employee knows never happened.

Brand Claims for Generic Drugs

The third allegation concerned what the pharmacy supplied. The government said Campbell Drug billed Medicare and Medicaid for brand-name medications while dispensing generic versions of the same drugs. Its announcement identified the financial reason for that mismatch: the brand-name medications carried higher reimbursement rates.

The pharmacy allegedly supplied the generic and billed for the more highly reimbursed brand. The patient could receive medication while the payer received the wrong description of it. In this part of the case, tracing whether a drug was dispensed leaves another question to answer: which product was it?

Why the Product on the Claim Matters

The drug’s movement and the payment arrangements follow different paths. The physical supply chain runs from manufacturer to wholesaler to dispenser. At the pharmacy, the claim sends information about that product into a payment system. A product moving through inventory and a claim moving toward payment leave different records to compare.

The Portsmouth thesis also explains the electronic transaction. Pharmacists or technicians send the National Drug Code with patient and drug information to a pharmacy benefit manager. The response communicates approval, denial or rejection and the amount payable to the pharmacy.

In Campbell Drug’s alleged brand-for-generic billing, that product comparison gets to the payment incentive. The government said the claim sought the brand’s higher reimbursement. We follow the billed product back to the dispensing record to see where the descriptions diverge.

Pharmacy Claims for Drugs Never Picked up or Shipped

Other pharmacy cases show how a paid claim can become detached from the drug reaching a patient. In the Walgreens settlement announced in September 2024, the government resolved allegations involving prescriptions that were processed but never picked up.

DaVita Rx’s December 2017 settlement included allegations involving drugs never shipped or returned, along with inadequate delivery and refill documentation. The whistleblowers’ amended complaint described how an insurance test allegedly became a paid claim:

The alleged test produced real payment even though no medicine went out. The same complaint alleged that medication left uncollected remained unreversed and the government was not reimbursed. That makes the later handling of a claim part of the transaction too: a shipment, pickup, return or reversal can change what the pharmacy’s original bill says happened.

The Pharmacy Records Behind the Allegations

For these billing practices, we connect prescription authorization, dispensing, product identity and claim history. Campbell Drug’s allegations show why each has a separate job. A prescription answers the authorization question, a dispensing record addresses whether medication was supplied, and the product detail tests whether the bill described the drug the patient received.

The Walgreens and DaVita allegations add pickup, delivery and reversal records to that comparison. An employee familiar with those operations can explain why a paid claim remained on the books after the underlying transaction failed to happen. We work with that knowledge and the business records together, including what the people responsible for billing knew about the discrepancy.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

You Know What the Pharmacy Actually Supplied

If you handled prescriptions, dispensing or claim reconciliation and saw the bill tell a different story, speak to one of our whistleblower experts about building your strongest pharmacy whistleblower case. We build the case with you and bring in pharmaceutical fraud whistleblower lawyers who understand Medicare and Medicaid pharmacy billing. You bring the view from inside the pharmacy, and we stay beside you through the pursuit of a recovery.